134 related articles for article (PubMed ID: 21653656)
1. Ezrin expression predicts local recurrence and development of metastases in soft tissue sarcomas.
Carneiro A; Bendahl PO; Åkerman M; Domanski HA; Rydholm A; Engellau J; Nilbert M
J Clin Pathol; 2011 Aug; 64(8):689-94. PubMed ID: 21653656
[TBL] [Abstract][Full Text] [Related]
2. Soft tissue sarcoma. Epidemiology and prognosis in 508 patients.
Gustafson P
Acta Orthop Scand Suppl; 1994 Jun; 259():1-31. PubMed ID: 8042499
[TBL] [Abstract][Full Text] [Related]
3. Local recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project.
Trovik CS;
Acta Orthop Scand Suppl; 2001 Feb; 72(300):1-31. PubMed ID: 11381580
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of immunohistochemical expression of ezrin in highly malignant soft tissue sarcomas.
Weng WH; Ahlén J; Aström K; Lui WO; Larsson C
Clin Cancer Res; 2005 Sep; 11(17):6198-204. PubMed ID: 16144921
[TBL] [Abstract][Full Text] [Related]
5. Improved prognostication in soft tissue sarcoma: independent information from vascular invasion, necrosis, growth pattern, and immunostaining using whole-tumor sections and tissue microarrays.
Engellau J; Bendahl PO; Persson A; Domanski HA; Akerman M; Gustafson P; Alvegård TA; Nilbert M; Rydholm A
Hum Pathol; 2005 Sep; 36(9):994-1002. PubMed ID: 16153463
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor type 1 receptor expression correlates to good prognosis in highly malignant soft tissue sarcoma.
Ahlén J; Wejde J; Brosjö O; von Rosen A; Weng WH; Girnita L; Larsson O; Larsson C
Clin Cancer Res; 2005 Jan; 11(1):206-16. PubMed ID: 15671548
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in soft tissue sarcoma. Tissue microarray for immunostaining, the importance of whole-tumor sections and time-dependence.
Engellau J
Acta Orthop Scand Suppl; 2004 Dec; 75(314):2 p preceding table of contents-52, backcover. PubMed ID: 15678700
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of proliferation in pleomorphic soft tissue sarcomas: a new look at an old measure.
Seinen JM; Jönsson M; Bendahl PO; Baldetorp B; Rambech E; Åkerman M; Rydholm A; Nilbert M; Carneiro A
Hum Pathol; 2012 Dec; 43(12):2247-54. PubMed ID: 22789784
[TBL] [Abstract][Full Text] [Related]
9. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].
Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for survival in patients with locally recurrent extremity soft tissue sarcomas.
Eilber FC; Brennan MF; Riedel E; Alektiar KM; Antonescu CR; Singer S
Ann Surg Oncol; 2005 Mar; 12(3):228-36. PubMed ID: 15827815
[TBL] [Abstract][Full Text] [Related]
11. Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevance.
Massi D; Beltrami G; Capanna R; Franchi A
Eur J Surg Oncol; 2004 Dec; 30(10):1131-6. PubMed ID: 15522563
[TBL] [Abstract][Full Text] [Related]
12. [Results of radiotherapy in recurrences of soft tissue sarcomas].
Schwarz R; Krüll A; Baumann M; Zornig C; Wiegel T; Weh HJ
Strahlenther Onkol; 1996 Feb; 172(2):64-73. PubMed ID: 8669047
[TBL] [Abstract][Full Text] [Related]
13. Time dependence of prognostic factors for patients with soft tissue sarcoma: a Scandinavian Sarcoma Group Study of 338 malignant fibrous histiocytomas.
Engellau J; Anderson H; Rydholm A; Bauer HC; Hall KS; Gustafson P; Akerman M; Meis-Kindblom J; Alvegård TA; Nilbert M;
Cancer; 2004 May; 100(10):2233-9. PubMed ID: 15139069
[TBL] [Abstract][Full Text] [Related]
14. Ezrin expression in tissue microarray of primary and recurrent gliomas.
Tynninen O; Carpén O; Jääskeläinen J; Paavonen T; Paetau A
Neuropathol Appl Neurobiol; 2004 Oct; 30(5):472-7. PubMed ID: 15488023
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.
Zagars GK; Ballo MT; Pisters PW; Pollock RE; Patel SR; Benjamin RS; Evans HL
Cancer; 2003 May; 97(10):2530-43. PubMed ID: 12733153
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of ezrin expression in pleomorphic malignant fibrous histiocytoma.
Kim MS; Cho WH; Song WS; Lee SY; Jeon DG
Anticancer Res; 2007; 27(2):1171-8. PubMed ID: 17465259
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.
Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P
Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy to improve local control regardless of surgical margin and malignancy grade in extremity and trunk wall soft tissue sarcoma: a Scandinavian sarcoma group study.
Jebsen NL; Trovik CS; Bauer HC; Rydholm A; Monge OR; Hall KS; Alvegård T; Bruland OS
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1196-203. PubMed ID: 18207661
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors for surgical treatment of soft-tissue sarcomas in dogs: 75 cases (1986-1996).
Kuntz CA; Dernell WS; Powers BE; Devitt C; Straw RC; Withrow SJ
J Am Vet Med Assoc; 1997 Nov; 211(9):1147-51. PubMed ID: 9364229
[TBL] [Abstract][Full Text] [Related]
20. Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer.
Elzagheid A; Korkeila E; Bendardaf R; Buhmeida A; Heikkilä S; Vaheri A; Syrjänen K; Pyrhönen S; Carpén O
Hum Pathol; 2008 Dec; 39(12):1737-43. PubMed ID: 18701134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
